Decoding Wegovy Doses: Your Path to Sustainable Weight Management

Last reviewed: July 1, 2026

Last updated: July 1, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Wegovy, functions as a glucagon-like peptide-1 (GLP-1) receptor agonist that reduces hunger signals in the brain and slows stomach emptying. The medication follows a structured dosing protocol that typically starts low and increases over 16 weeks to allow your body to adapt. Understanding how this escalation works helps you set realistic expectations and commit to long-term weight management success.

How Semaglutide Dosing Schedules Build Over Time

Semaglutide treatment begins with a 0.25 mg injection once weekly for the first four weeks. This introductory dose allows your body to become accustomed to the medication while minimizing gastrointestinal side effects like nausea. Most patients tolerate this starting level well and can continue their normal eating patterns while the appetite-suppressing effects begin to work.

The dose increases by 0.25 mg each month, reaching 0.5 mg in week five, 0.75 mg in week nine, and 1.0 mg in week thirteen. By week seventeen, many patients reach a maintenance dose of 1.0 to 2.4 mg weekly, depending on their response and tolerance. This measured progression helps your body adapt gradually rather than introducing sudden changes that could trigger side effects.

The escalation schedule is intentional: it gives your metabolism time to reset while your brain's hunger centers become increasingly sensitive to the GLP-1 signal. Research shows that gradual dosing leads to better long-term adherence compared to rapid increases, because patients experience fewer disruptive side effects during the titration phase.

Why Titration Matters for Weight Loss Sustainability

Rapid dose jumps can overwhelm your system, causing severe nausea, vomiting, or loss of appetite that makes eating nearly impossible. A slow titration schedule allows you to find your personal tolerance threshold and adjust your eating habits gradually, creating sustainable behavioral change rather than forced dietary restriction. This approach supports continued weight loss over months and years rather than a short-term crash.

The four-week intervals between dose increases also give you time to observe how your appetite, energy levels, and weight respond at each tier. Some patients reach their weight loss goals at lower doses (0.5 to 1.0 mg) and maintain long-term success without advancing further. Others find they need higher doses, and the scheduled progression gives you the flexibility to make informed decisions with your provider about whether to continue advancing.

Semaglutide Dosing vs. Other GLP-1 Options

Semaglutide injections are dosed once per week, whereas oral semaglutide tablets require daily dosing at higher pill amounts to achieve similar effects. Weekly injection dosing improves adherence for many patients because it requires only one step per week rather than daily remembering. PlexusDx offers both compounded semaglutide injection and oral semaglutide, allowing you to choose the delivery method that fits your lifestyle.

Tirzepatide, a dual GIP/GLP-1 receptor agonist, follows a similar titration pattern but typically produces greater weight loss in clinical trials—an average of 20-22% body weight reduction compared to semaglutide's 15-18%. Both medications start at low doses and escalate weekly, but they bind to different receptor pathways in your body. PlexusDx Precision Peptide Genetic Test can describe the pathway-level variants involved.

Starting Semaglutide at PlexusDx: Cost and Access Without Insurance

PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan), a flat fee that covers your dose regardless of level. Your dose may need to go up during titration, but your price won't—you pay the same monthly rate whether you're at the starting 0.25 mg or a maintenance dose of 2.4 mg. This transparent pricing removes the guesswork and financial anxiety that often delays people from starting treatment.

All PlexusDx medications come from licensed 503A compounding pharmacies, meet USP standards, and are available to patients in all 50 states without insurance requirements. Treatment plans are HSA and FSA eligible, and PlexusDx doesn't charge membership fees or require long-term contracts. Adding the Precision Peptide Genetic Test ($298) allows your provider to map 14 peptide pathways and 49 distinct peptides, personalizing your long-term weight management strategy based on your genetic predispositions.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Will my semaglutide dose increase every month?

Yes, the standard titration schedule increases your dose by 0.25 mg every four weeks until you reach a maintenance dose (typically 1.0–2.4 mg weekly). However, your provider can pause or adjust increases if you experience side effects or reach your weight loss goals at a lower dose. PlexusDx providers work with you to find the optimal dose for your body.

How much weight do people lose on semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Why does semaglutide cost $189 per month at PlexusDx?

PlexusDx compounds semaglutide in licensed 503A pharmacies and distributes directly to patients in all 50 states without insurance middlemen. The $189 flat monthly rate applies regardless of your current dose, and there are no additional membership, consultation, or delivery fees. HSA and FSA funds cover the cost, making it accessible for most budgets.

What are the most common side effects during semaglutide titration?

Nausea, vomiting, constipation, and reduced appetite are most frequent during the first 4–8 weeks, especially when doses increase. These effects typically ease as your body adapts. Staying hydrated, eating smaller frequent meals, and avoiding high-fat foods reduce symptom severity. Serious side effects are rare but should be reported to your provider immediately.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR (rs1800437), FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy For Losing Weight
• Wegovy For Weight Loss 2
• Wegovy Weight Loss Pills
• Wegovy Vs Zepbound Weight Loss

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.